The LifeSci Biotechnology Clinical Trials Index is an equal-weighted index comprised of US-listed biotechnology stocks with a lead product in human clinical trials but not yet approved for marketing. The index is reconstituted semi-annually and is provided by LifeSci Index Partners, LLC.
